… in the treatment of chronic obstructive pulmonary disease (COPD) remains controversial …
effect of inhaled fluticasone propionate with placebo in the treatment of patients with COPD. …

… It seems that only certain subgroups of patients with COPD … fluticasone propionate (FP)
had an effect on lung function and on indices of inflammation in a subgroup of COPD patients …

… ) study in COPD showed a 26% reduction in the yearly rate of exacerbations in patients
treated with fluticasone propionate (FP) compared to placebo, but did not indicate which patients …

… , multicenter study evaluated the effect of fluticasone propionate/salmeterol 250 mcg/50 mcg
(… management of COPD exacerbations and support the use of FSC in patients with COPD. …

… fluticasone propionate … Fluticasone propionate 500 μg twice daily did not affect the rate of
decline in FEV 1 but did produce a small increase in FEV 1 . Patients on fluticasone propionate …

… In conclusion, regular use of fluticasone propionate alone or in combination with salmeterol
is associated with increased survival of chronic obstructive pulmonary disease patients …

… In conclusion, withdrawal of fluticasone in patients with COPD results in persistent
deterioration in lung function, an increase in mild exacerbations, dyspnoea and percentage of …

… COPD patients with forced expiratory volume in 1 s (FEV 1 ) … and non-eosinophilic COPD
phenotypes and a large ongoing … Flutiform ® is a fixed combination of fluticasone propionate …

… and 90 days after treatment in COPD patients treated with salmeterol alone and those …
fluticasone propionate (for each group, n = 20). COPD, chronic obstructive pulmonary disease…

… The purpose of this study was to assess the effect of inhaled fluticasone propionate on cell
… in patients with chronic bronchitis and emphysema. Fluticasone propionate was chosen …